Overview:  Large language models may dominate headlines, but modern NLP tools remain essential for text processing, ...

GitLab 19.0 extends agentic AI beyond code generation into securing credentials, reviewing and merging changes, and scanning ...

Artificial intelligence is accelerating content creation at a pace few people could have imagined even a few years ago, yet the brands that earn lasting relevance in the years ahead will not be ...

The Futures and Concepts Command (FCC) is designing the future force by developing integrated concepts and requirements, informed by experimentation, and synchronized into T2COM and Army processes to ...

It’s a sad day for millennials that reside in Canada, and it’s all because their childhood is slowly withering away. The Canadian operator of the Toys R Us brand has undergone Canada’s equivalent of ...

The Canadian operator of the Toys R Us brand has undergone Canada’s equivalent of Chapter 11 bankruptcy. Toys R Us Canada no longer has any connection to the original U.S. company or the company ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Alfac’s call center is 450 employees deep, and artificial intelligence is a prime tool to help agents give detailed information to the 15,000 calls the supplemental insurance brand receives daily, ...

OpenAI is rolling out new interactive responses in ChatGPT it says are designed to make the chatbot more useful for learners. Starting today, ChatGPT will generate dynamic visuals when you ask it to ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...